Exploring rifamycin cytotoxic potential through targeted liposomal formulations.
Saved in:
| Title: | Exploring rifamycin cytotoxic potential through targeted liposomal formulations. |
|---|---|
| Authors: | Ataide JA; Center for Pharmaceutical Biotechnology and Nanomedicine, Dept. of Pharmaceutical Science, Northeastern University, USA; Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Brazil., Filipczak N; Center for Pharmaceutical Biotechnology and Nanomedicine, Dept. of Pharmaceutical Science, Northeastern University, USA. Electronic address: nina.filipczak@gmail.com., Yalamarty SSK; Center for Pharmaceutical Biotechnology and Nanomedicine, Dept. of Pharmaceutical Science, Northeastern University, USA., Rajmalani BA; Center for Pharmaceutical Biotechnology and Nanomedicine, Dept. of Pharmaceutical Science, Northeastern University, USA., Luther E; Dept. of Pharmaceutical Sciences, Northeastern University, USA., Mazzola PG; Faculty of Pharmaceutical Sciences, University of Campinas (Unicamp), Brazil., Torchilin VP; Center for Pharmaceutical Biotechnology and Nanomedicine, Dept. of Pharmaceutical Science, Northeastern University, USA. |
| Source: | International journal of pharmaceutics [Int J Pharm] 2026 May 20; Vol. 697, pp. 126880. Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
